Horizon Pharma is a specialty pharmaceutical company that has developed and is focused on commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in the areas of arthritis, pain and inflammatory disease. The company’s strategy involves developing, acquiring, in-licensing and or/co-promoting additional innovative medicines for which it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of company commercial strengths and infrastructure. For more information, visit the company’s Web site: http://www.horizonpharma.com

Let us hear your thoughts below: